GENE ONLINE|News &
Opinion
Blog

Editors' Picks
JPM 2026 Billion dollar deal
First-of-Its-Kind AI Drug Discovery Lab: NVIDIA, Eli Lilly Announce $1B Investment at J.P. Morgan Healthcare
2026-01-12
Deals Big Pharma licensingAmgenLicensing Deals
DISCO Pharmaceuticals and Amgen Ink Exclusive License Deal to Advance Surfaceome-Targeted Cancer Therapies
2026-01-07
Bora Pharmaceuticals become the First Pharmaceuticals in Taiwan to trade on OTCQX
2026-01-08
Editors' Picks JPM
Resilience Over Expansion: What J.P. Morgan’s 2026 Outlook Reveals About Business Strategy Amid Macro Uncertainty
As the global investment community prepares for the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, new data suggests a corporate landscape defined …

Home Read More »

2026-01-08
Deals Eli LillyAcquisitions
Lilly Commits $1.2B to Transform Oral Therapy Landscape with Ventyx Acquisition
2026-01-08
Special
Asia Pacific Cell TherapyClonell Therapeuticssomatic cell nuclear transfer
South Korea’s Clonell Unveils “Ultimate Regenerative Medicine Platform,” Promising Patient-Specific Stem Cells to Tackle Immune Rejection
On Jan 5, South Korean biotech company Clonell Therapeutics has announced its “Ultimate Regenerative Medicine Platform,” claiming it can generate patient-specific embryonic stem cell sources …

South Korea’s Clonell Unveils “Ultimate Regenerative Medicine Platform,” Promising Patient-Specific Stem Cells to Tackle Immune Rejection Read More »

2026-01-07
Trending
New Year 2026: Why Your Healthcare Is Getting a Massive Upgrade This Year
Forget the old “New Year, New Me” gym clichés; for 2026, the real glow-up is happening in your doctor’s office. As we ring in New …

New Year 2026: Why Your Healthcare Is Getting a Massive Upgrade This Year Read More »

2025-12-31
The Fifth Pillar: How Light and Precision are Changing the Standard of Cancer Care
For decades, the “Big Three” of oncology—surgery, radiation, and chemotherapy—have functioned as a blunt instrument. While effective at killing tumors, the collateral damage is often …

The Fifth Pillar: How Light and Precision are Changing the Standard of Cancer Care Read More »

2025-12-28
LATEST
Family Involvement in ICU Decision-Making Linked to Improved Patient Outcomes in Saudi Arabia
2026-01-13
New Healthcare Model OPEN AOS Developed to Address Emergency Needs of Elderly Patients
2026-01-13
Study Explores Role of Interleukin-6 in Cancer Cachexia and Effects of Exercise on Muscle Wasting
2026-01-13
Study Finds Link Between Dietary Folate Intake and Obesity Risk in Children and Adolescents
2026-01-13
Study Explores Nursing Competence in Integrating Traditional and Modern Practices in Hunan’s Chinese Medicine Hospitals
2026-01-13
Study Reveals Healthcare Providers Face Challenges in Prescribing Pancreatic Enzyme Replacement Therapy
2026-01-13
Research Explores Evaluation Frameworks for AI Scribing Technology in Healthcare
2026-01-13
READ MORE
Deals
Funding
Funding biotech funding
Rakuten Medical Closes $100 Million Series F to Push Lead Cancer Therapy Toward FDA Review
2026-01-09
Early 2026 Biotech Fundraising: Parabilis and EpiBiologics Secure Major Rounds to Advance Oncology Pipelines
2026-01-09
Evergreen VC Fund Drives Cross-sector Synergy, Connecting Global and Taiwanese Biotech Ecosystems
2025-12-10
IPO
Ahead of the Curve: Elixiron’s Immune-First Path to a Vitiligo Lead
2025-12-23
LB Pharmaceuticals Files for $100 Million IPO to Fund Schizophrenia Drug Trial
2025-08-27
Investor Trust and Market Timing Shape the New IPO Playbook
2025-06-18
M&A
Johnson & Johnson
J&J Acquires Halda to Boost RIPTAC Based Oral Prostate Cancer Therapy
2025-11-19
Is Genmab’s New Asset the Next Big Bet in PD-1 Combination Therapy for Head and Neck Cancer?
2025-10-01
Genmab–Merus Acquisition: An $8 Billion Bet to Own Late-Stage Oncology
2025-10-01
Ranking & Reports
Ranking & Reports
In-Depth global market
HIV Therapeutics at a Crossroads as Long-Acting Drugs Meet Geopolitical Risk
2025-12-30
East vs. West: Diverging Philosophies in Health Insurance Reform
2025-11-13
The 2025 Alzheimer’s Drug Pipeline: Market Projections and Clinical Breakthroughs
2025-09-02
VIDEOS
“To Conquer Cancer with Light” — Minami M., President of Rakuten Medical
15:48
“To Conquer Cancer with Light” — Minami M., President of Rakuten Medical
“To Conquer Cancer with Light” — Minami M., President of Rakuten ...
Moderna’s mRNA Next Act: Cancer, RSV & Rare Diseases
01:58
Moderna’s mRNA Next Act: Cancer, RSV & Rare Diseases
In this interview, we dive into Moderna’s evolving strategy with ...
Dr. Wafa Samara on Pharmacy’s Evolving Strategic Role
02:01
Dr. Wafa Samara on Pharmacy’s Evolving Strategic Role
In this interview, Dr. Wafa Samara explores how pharmacy is evolving ...
Fighting Alzheimer’s by Reversing Brain Aging and Boosting Resilience
02:29
Fighting Alzheimer’s by Reversing Brain Aging and Boosting Resilience
Dr. Tseng, CEO of Acroviz breaks down the science behind “brain age” ...
The 3 Pillars of Taiwan Biotech
12:29
The 3 Pillars of Taiwan Biotech
TK Li showcases how integrating medicine, technology, and food creates ...
DCB, FIRDI & ITRI Spotlight Breakthrough Biotech at BIO Asia–Taiwan
05:54
DCB, FIRDI & ITRI Spotlight Breakthrough Biotech at BIO Asia–Taiwan
At the BIO Asia–Taiwan 2025, GeneOnline visited the pavilions of the ...
Inside 2025 BIO Asia-Taiwan CMU Pavilion: Breakthroughs in CAR-T, Exosomes & Antibodies
08:59
Inside 2025 BIO Asia-Taiwan CMU Pavilion: Breakthroughs in CAR-T, Exosomes & Antibodies
At the 2025 BIO Asia–Taiwan, GeneOnline visited the China Medical ...
New DDB2-Targeting Strategy for Metastatic TNBC by CMU
New DDB2-Targeting Strategy for Metastatic TNBC by CMU
GeneOnline sat down with Hsin-Chiao Chou (Ilsa Chou), Postdoctoral ...
CytoArm CEO on Next-Gen Solid Tumor Immunotherapy
CytoArm CEO on Next-Gen Solid Tumor Immunotherapy
While CAR-T therapies have revolutionized treatment for blood cancers, ...
PlasmonicTron CEO on Retinal Organoid Innovation
00:29
PlasmonicTron CEO on Retinal Organoid Innovation
With aging populations worldwide, degenerative eye diseases like ...
Australia Pavilion Showcases Clinical Trial Excellence at BIO Asia
00:37
Australia Pavilion Showcases Clinical Trial Excellence at BIO Asia
At BIO Asia–Taiwan 2025, the Australia Pavilion brought together 24 ...
Phoenix Rising as a Global Health-Tech Hub
Phoenix Rising as a Global Health-Tech Hub
Phoenix is emerging as one of the most compelling stories in the ...
Scaling Medtech Startups Globally: Insights from Experts
Scaling Medtech Startups Globally: Insights from Experts
“What doctors want isn’t always what hospitals buy or what insurers ...
BIO Asia–Taiwan 2025: Taiwan’s Global Biotech Showcase
BIO Asia–Taiwan 2025: Taiwan’s Global Biotech Showcase
BIO Asia–Taiwan 2025 is just around the corner, returning to Taipei ...
ITRI Advances Ophthalmology and Cell Therapy Innovations
05:41
ITRI Advances Ophthalmology and Cell Therapy Innovations
In an interview with GeneOnline during BIO International Convention ...
AP Biosciences’ Dual Platforms for Cancer Immunotherapy
AP Biosciences’ Dual Platforms for Cancer Immunotherapy
In an interview with Spike Lo at BIO International Convention 2025, ...
BioMap CEO Wei Liu on AI Drug Discovery
02:46
BioMap CEO Wei Liu on AI Drug Discovery
Wei LIU, CEO of BioMap, points out that while AI is accelerating ...
Hong Kong’s Bold Push to Transform Global Health: Biotech, Medtech, and Beyond
Hong Kong’s Bold Push to Transform Global Health: Biotech, Medtech, and Beyond
The global health landscape faces intense pressure: aging populations, ...
DCB Driving Taiwan’s Exosome and EV Therapy Innovation
DCB Driving Taiwan’s Exosome and EV Therapy Innovation
At the heart of Taiwan’s biotech transformation, the Development ...
Verastem Oncology’s Dual Approach to Aggressive Cancers
01:33
Verastem Oncology’s Dual Approach to Aggressive Cancers
“Don’t just target the cancer cell—focus on the stroma too.” That’s ...
Categories
Interviews
Investors Eye Bispecific Antibodies as Clinical Data Drives Decisions
2025-12-31
The Fifth Pillar: How Light and Precision are Changing the Standard of Cancer Care
2025-12-28
Ahead of the Curve: Elixiron’s Immune-First Path to a Vitiligo Lead
2025-12-23
Asia-Pacific
Bora Pharmaceuticals become the First Pharmaceuticals in Taiwan to trade on OTCQX
2026-01-08
Evergreen VC Fund Drives Cross-sector Synergy, Connecting Global and Taiwanese Biotech Ecosystems
2025-12-10
A New Order in APAC Biosimilar Market: From Manufacturing Powerhouses to Value-Driven Innovators
2025-11-13
Trials & Approvals
Trending Clinical Trial
2026 Drug Watch: Top Clinical Trials Shaping the Future of Medicine
2026-01-07
FDA Approves PADCEV and Keytruda Perioperative Therapy: A Game-Changer for Cisplatin-Ineligible Bladder Cancer Patients
2025-11-27
AstraZeneca’s Imfinzi Wins U.S. Approval for Perioperative Gastric Cancer Treatment with FLOT
2025-11-26
China
Asia Pacific China policy
Hainan Biotech: Could the Free Trade Port Launch China’s Next Global Giant?
2025-12-30
Indian Generics Gain Ground in China as the Global Procurement Landscape Demands a New Industrial Model
2025-11-13
BMS to Sell 60% Stake in China JV SASS, Marking a Four-Decade Turning Point
2025-09-18
Startups
Funding OncologyProtein Degradersfinancing
Early 2026 Biotech Fundraising: Parabilis and EpiBiologics Secure Major Rounds to Advance Oncology Pipelines
2026-01-09
From Lab Bench to Global Market: A Practical Playbook for Japan’s Biotech Startups
2025-10-14
German Startup BIOWEG Raises €16M to Tackle Plastic Waste with Biodegradables
2025-09-18
Manufacturing
Bora Pharmaceuticals become the First Pharmaceuticals in Taiwan to trade on OTCQX
2026-01-08
Indian Generics Gain Ground in China as the Global Procurement Landscape Demands a New Industrial Model
2025-11-13
The Biologics Landscape Is Changing—Fast: CDMOs Race to Integrate Development, Scale, and Next-Gen Modalities
2025-10-20
Licensing
Deals Big Pharma licensingAmgenLicensing Deals
DISCO Pharmaceuticals and Amgen Ink Exclusive License Deal to Advance Surfaceome-Targeted Cancer Therapies
2026-01-07
HIV Therapeutics at a Crossroads as Long-Acting Drugs Meet Geopolitical Risk
2025-12-30
Senti Bio Wins FDA RMAT Designation for SENTI-202 on 50% Response Rate in Leukemia Trial
2025-12-11
R&D
R&D South Korea BiotechCancer Vaccine
AI-Designed B Cell–Reactive Neoantigens Open a New Chapter for Personalized Cancer Vaccines
2026-01-05
Investors Eye Bispecific Antibodies as Clinical Data Drives Decisions
2025-12-31
A Harvard-led Colibactin Study Reveals How Gut Microbes Cross-Link DNA to Raise Colorectal Cancer Risk
2025-12-30
Technology
The Fifth Pillar: How Light and Precision are Changing the Standard of Cancer Care
2025-12-28
South Korea Backs High-Tech Overhaul of Ancient Medicine for Global Market
2025-12-10
Slovakia Taps Digital Diagnostics to Address Cardiovascular Crisis and Efficiency Gaps
2025-12-09
EVENT
2026-01-12
J.P. Morgan Healthcare Conference
San Francisco, California
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-10
Bioprocessing Summit Europe (Biomanufacturing Trends)
Barcelona, Spain
SEE MORE
Scroll to Top